Page last updated: 2024-11-08

aspartic acid and Amyotrophic Lateral Sclerosis

aspartic acid has been researched along with Amyotrophic Lateral Sclerosis in 105 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research Excerpts

ExcerptRelevanceReference
"A study was conducted to examine the effect of lamotrigine (LTG) in amyotrophic lateral sclerosis (ALS)."9.10A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters. ( Askmark, H; Persson, LI; Ryberg, H, 2003)
"A study was conducted to examine the effect of lamotrigine (LTG) in amyotrophic lateral sclerosis (ALS)."5.10A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters. ( Askmark, H; Persson, LI; Ryberg, H, 2003)
"Riluzole, a glutamate antagonist, has been shown to be efficacious in the treatment of patients with amyotrophic lateral sclerosis (ALS), allowing prolonged survival and time to tracheostomy."5.08Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. ( Arnold, DL; Cashman, NR; Genge, A; Kalra, S, 1998)
"Changes in the distribution of the proton magnetic resonance spectroscopy (MRS) observed metabolites N-acetyl aspartate (NAA), total-choline (Cho), and total-creatine (Cre) in the entire intracranial corticospinal tract (CST) including the primary motor cortex were evaluated in patients with amyotrophic lateral sclerosis (ALS)."3.78Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. ( Arheart, KL; Govind, V; Maudsley, AA; Saigal, G; Sharma, KR; Sheriff, S, 2012)
"The Aspartate-90-Alanine (D90A) mutation on SOD-1 gene, the only known change causing recessive familial amyotrophic lateral sclerosis (FALS), is associated with a uniform phenotype characterized by slowly ascending paresis and long survival."3.71A screening for superoxide dismutase-1 D90A mutation in Italian patients with sporadic amyotrophic lateral sclerosis. ( Del Corona, A; Filosto, M; Mancuso, M; Murri, L; Naini, A; Rocchi, A; Sartucci, F; Siciliano, G, 2002)
"Frontotemporal lobar degeneration is responsible for the cognitive abnormalities seen in patients with ALS."2.76Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study. ( Camicioli, R; Choi, C; Johnston, W; Kalra, S; Lynch, M; Sekhon, R; Seres, P; Usman, U, 2011)
"However, an objective measure of disease progression and therapeutic response is sorely needed."2.40Biological markers in the diagnosis and treatment of ALS. ( Arnold, DL; Cashman, NR; Kalra, S, 1999)

Research

Studies (105)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.95)18.7374
1990's30 (28.57)18.2507
2000's37 (35.24)29.6817
2010's33 (31.43)24.3611
2020's4 (3.81)2.80

Authors

AuthorsStudies
Natera-de Benito, D1
Olival, J1
Garcia-Cabau, C1
Jou, C1
Roldan, M1
Codina, A1
Expósito-Escudero, J1
Batlle, C1
Carrera-García, L1
Ortez, C1
Salvatella, X1
Palau, F1
Nascimento, A1
Hoenicka, J1
Blicher, JU1
Eskildsen, SF1
Stærmose, TG1
Møller, AT1
Figlewski, K1
Near, J1
Canosa, A1
Grassano, M1
Barberis, M1
Brunetti, M1
Manera, U1
Vasta, R1
Cammarosano, S1
De Marco, G1
Calvo, A1
Chiò, A1
Moglia, C1
Sako, W2
Izumi, Y2
Abe, T2
Haji, S1
Murakami, N1
Osaki, Y1
Matsumoto, Y1
Harada, M2
Kaji, R2
Ta, D1
Ishaque, A1
Srivastava, O1
Hanstock, C3
Seres, P2
Eurich, DT1
Luk, C1
Briemberg, H1
Frayne, R1
Genge, AL1
Graham, SJ1
Korngut, L1
Zinman, L1
Kalra, S10
Atassi, N1
Xu, M1
Triantafyllou, C1
Keil, B1
Lawson, R1
Cernasov, P1
Ratti, E1
Long, CJ1
Paganoni, S1
Murphy, A1
Salibi, N1
Seethamraju, R1
Rosen, B1
Ratai, EM1
Piaceri, I1
Bessi, V1
Matà, S1
Polito, C1
Tedde, A1
Berti, V1
Bagnoli, S1
Braccia, A1
Del Mastio, M1
Pignone, AM1
Pupi, A1
Sorbi, S1
Nacmias, B1
Cheong, I1
Deelchand, DK1
Eberly, LE1
Marjańska, M1
Manousakis, G1
Guliani, G1
Walk, D1
Öz, G1
de Munck, E1
Muñoz-Sáez, E1
Miguel, BG1
Solas, MT1
Ojeda, I1
Martínez, A1
Gil, C1
Arahuetes, RM1
D'Angelo, S1
Trojsi, F1
Salvatore, A1
Daniele, L1
Raimo, M1
Galletti, P1
Monsurrò, MR2
Shi, Y1
Rhodes, NR1
Abdolvahabi, A1
Kohn, T1
Cook, NP1
Marti, AA1
Shaw, BF1
Cervo, A1
Cocozza, S1
Saccà, F1
Giorgio, SMDA1
Morra, VB1
Tedeschi, E1
Marsili, A1
Vacca, G1
Palma, V1
Brunetti, A1
Quarantelli, M1
Barthelme, D1
Jauregui, R1
Sauer, RT1
García Santos, JM1
Inuggi, A1
Gómez Espuch, J1
Vázquez, C1
Iniesta, F1
Blanquer, M1
María Moraleda, J1
Martínez, S1
Corsini, S1
Tortora, M1
Nistri, A2
Wang, Y2
Li, X1
Chen, W1
Wang, Z1
Xu, Y1
Luo, J1
Lin, H1
Sun, G1
Mali, Y2
Zisapels, N1
Pyra, T2
Hui, B2
Concha, L1
Wong, JC1
Beaulieu, C1
Johnston, W3
Kosuge, Y1
Sekikawa-Nishida, K1
Negi, H1
Ishige, K1
Ito, Y1
Fiszman, ML1
Ricart, KC1
Latini, A1
Rodríguez, G1
Sica, RE1
Choi, JK1
Küstermann, E1
Dedeoglu, A1
Jenkins, BG1
Young, K1
Govind, V2
Sharma, K1
Studholme, C1
Maudsley, AA6
Schuff, N5
Lombardo, F1
Frijia, F1
Bongioanni, P1
Canapicchi, R1
Minichilli, F1
Bianchi, F1
Hlavata, H1
Rossi, B1
Montanaro, D1
Zisapel, N1
Sivák, S1
Bittšanský, M1
Kurča, E1
Turčanová-Koprušáková, M1
Grofik, M1
Nosál', V1
Poláček, H1
Dobrota, D1
Nagańska, E1
Taraszewska, A1
Matyja, E1
Grieb, P1
Rafałowska, J1
Georgoulopoulou, E1
Gellera, C1
Bragato, C1
Sola, P1
Chiari, A1
Bernabei, C1
Mandrioli, J1
Tolosa, L1
Caraballo-Miralles, V1
Olmos, G1
Lladó, J1
Sudharshan, N1
Cifra, A1
Nani, F1
Usman, U1
Choi, C1
Camicioli, R1
Lynch, M1
Sekhon, R1
Del Grande, A1
Conte, A1
Lattante, S1
Luigetti, M1
Marangi, G1
Zollino, M1
Madia, F1
Bisogni, G1
Sabatelli, M1
Carew, JD1
Nair, G1
Andersen, PM2
Wuu, J1
Gronka, S1
Hu, X1
Benatar, M1
Simone, IL2
Ruggieri, M1
Tortelli, R1
Ceci, E1
D'Errico, E1
Leo, A1
Zoccolella, S1
Mastrapasqua, M1
Capozzo, R1
Livrea, P1
Logroscino, G1
Uccelli, A1
Milanese, M2
Principato, MC1
Morando, S1
Bonifacino, T2
Vergani, L1
Giunti, D1
Voci, A1
Carminati, E1
Giribaldi, F2
Caponnetto, C1
Bonanno, G2
Foerster, BR1
Callaghan, BC1
Petrou, M1
Edden, RA1
Chenevert, TL1
Feldman, EL1
Sharma, KR1
Arheart, KL1
Saigal, G1
Sheriff, S2
Anna Rossi, PI1
Di Prisco, S1
Pittaluga, A1
Tacchetti, C1
Puliti, A1
Usai, C1
Stagg, CJ1
Knight, S1
Talbot, K1
Jenkinson, M1
Turner, MR1
Verma, G1
Woo, JH2
Chawla, S1
Wang, S2
Elman, LB2
McCluskey, LF2
Grossman, M1
Melhem, ER2
Poptani, H2
Cashman, NR4
Caramanos, Z1
Genge, A4
Arnold, DL6
Mancuso, M1
Filosto, M1
Naini, A2
Rocchi, A1
Del Corona, A1
Sartucci, F1
Siciliano, G1
Murri, L1
Shigeri, Y1
Shimamoto, K1
Ryberg, H1
Askmark, H1
Persson, LI1
Sato, T1
Yamamoto, Y1
Nakanishi, T1
Fukada, K1
Sugai, F1
Zhou, Z1
Okuno, T1
Nagano, S1
Hirata, S1
Shimizu, A1
Sakoda, S1
Yin, H1
Lim, CC1
Ma, L1
Gao, Y1
Cai, Y1
Li, D1
Liang, Y1
Guo, X1
Rule, RR1
Suhy, J2
Gelinas, DF1
Miller, RG3
Weiner, MW4
Banci, L1
Bertini, I1
D'Amelio, N1
Gaggelli, E1
Libralesso, E1
Matecko, I1
Turano, P1
Valentine, JS1
Vermeiren, C1
Hemptinne, I1
Vanhoutte, N1
Tilleux, S1
Maloteaux, JM1
Hermans, E1
Desiderio, LM1
Krejza, J1
Conforti, FL1
Sprovieri, T1
Mazzei, R1
Ungaro, C1
Tessitore, A1
Tedeschi, G1
Patitucci, A1
Magariello, A1
Gabriele, A1
Labella, V1
Majorana, G1
Valentino, P1
Muglia, M1
Quattrone, A1
Meyerhoff, DJ1
Mueller, S1
Chao, L1
Sacrey, DT1
Laxer, K1
Vitale, A1
Mehrazin, M1
Lu, J1
Gordon, P1
Mitsumoto, H4
Huang, H1
Tan, K1
Chen, L1
Xue, Y1
Wang, H1
Xi, H1
Liu, Y1
Zhang, F1
Zhang, J1
Unrath, A1
Ludolph, AC2
Kassubek, J1
Niessen, HG1
Debska-Vielhaber, G1
Sander, K1
Angenstein, F1
Hilfert, L1
Willker, W1
Leibfritz, D1
Heinze, HJ2
Kunz, WS2
Vielhaber, S2
Ulug, AM1
Pullman, SL1
Gooch, CL1
Chan, S2
Tang, MX1
Mao, X1
Hays, AP1
Floyd, AG1
Battista, V1
Montes, J1
Hayes, S1
Dashnaw, S1
Kaufmann, P1
Gordon, PH1
Hirsch, J1
Levin, B1
Rowland, LP2
Shungu, DC2
Jones, AP2
Gunawardena, WJ1
Coutinho, CM1
Gatt, JA1
Shaw, IC2
Mitchell, JD1
Gredal, O2
Møller, SE1
Shaw, PJ1
Chinnery, RM1
Ince, PG1
Fujita, K1
Nagata, Y1
Honda, M1
Blin, O2
Samuel, D2
Nieoullon, A2
Serratice, G1
Rothstein, JD4
Jin, L1
Dykes-Hoberg, M1
Kuncl, RW2
Plaitakis, A2
Constantakakis, E2
Giroud, M1
Walker, P1
Bernard, D1
Lemesle, M1
Martin, D1
Baudouin, N1
Brunotte, F1
Dumas, R1
Knight, JM1
Redmond, JP1
Rosenbaum, S1
Topp, S1
Karlsborg, M1
Strange, P1
Werdelin, L1
La Bella, V1
Goodman, JC1
Appel, SH1
Nilsson, P1
Forsgren, L1
Marklund, SL1
Ikeda, K1
Iwasaki, Y1
Kinoshita, M1
Ichijo, M1
Fujii, H1
Matsuoka, Y1
Irimajiri, S1
Rooney, WD1
Gelinas, D2
Kim, SM2
Eum, WS2
Kang, JH2
Ellis, CM1
Simmons, A1
Andrews, C1
Dawson, JM1
Williams, SC1
Leigh, PN1
Pioro, EP2
Moore, JK1
Ng, TC2
Trapp, BD1
Klinkosz, B1
Kwon, OB1
Majors, AW1
Nelson, DR1
Niebroj-Dobosz, I3
Janik, P2
Douglas-Akinwande, A1
Lange, DJ1
Bradley, WG1
Bowen, BC1
Pattany, PM1
Rotta, F1
Alexander, GM1
Deitch, JS1
Seeburger, JL1
Del Valle, L1
Heiman-Patterson, TD1
Aĭrapetian, KV1
Zavalishin, IA1
Nikitin, SS1
Barkhatova, VP1
Slominsky, PA1
Shadrina, MI1
Kondratyeva, EA1
Tupitsina, TV1
Levitsky, GN1
Skvortsova, VI1
Limborska, SA1
Pohl, C2
Block, W2
Karitzky, J1
Träber, F2
Schmidt, S2
Grothe, C2
Lamerichs, R1
Schild, H1
Klockgether, T2
Kenn, W1
Ochs, G1
Pabst, TA1
Hahn, D1
Abe, K1
Takanashi, M1
Watanabe, Y1
Tanaka, H1
Fujita, N1
Hirabuki, N1
Yanagihara, T1
Pels, H1
Schild, HH1
Kaufmann, J1
Kanowski, M1
Sailer, M1
Feistner, H1
Tempelmann, C1
Elger, CE1
Bak, MI1
Domzał-Stryga, A1
Królicki, L1
Kwieciński, H2
Rule, R1
Licht, J1
Dronsky, V1
Hanstock, CC1
Cwik, VA1
Martin, WR1
Kostera-Pruszczyk, A1
Emeryk-Szajewska, B1
Karwańska, A1
Rowińska-Marcińska, K1
Ono, S1
Yamauchi, M1
Guieu, R1
Pouget, J1
Serratrice, G1
Kuncl, R2
Chaudhry, V1
Clawson, L2
Cornblath, DR2
Coyle, JT3
Drachman, DB2
Tsai, GC1
Stauch-Slusher, B1
Sim, L1
Hedreen, JC1
Spink, DC1
Martin, DL1
Tsai, G1
Pestronk, A1
Stauch, BL1
Smith, J1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis[NCT02405182]145 participants (Actual)Observational2014-09-30Completed
The Relationship Between the Efficacy of Lumateperone and Central Glutamate and Dopaminergic Metabolism: A Comparison With Risperidone in First Episode Psychosis[NCT05890768]Phase 435 participants (Anticipated)Interventional2023-05-11Recruiting
Optimized Intracranial EEG Targeting in Focal Epilepsy Based Upon Neuroimaging Connectomics[NCT04649008]Early Phase 1290 participants (Anticipated)Interventional2021-03-01Recruiting
Muscle Ultrasound: A New Tool for Measuring Progression in ALS[NCT00838617]10 participants (Actual)Observational2009-02-28Completed
Nuclear Magnetic Spectroscopy for the Evaluation of Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis[NCT00023075]55 participants Observational2001-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for aspartic acid and Amyotrophic Lateral Sclerosis

ArticleYear
[Excitatory amino acid transporters: development of regulatory molecules for their functional analysis].
    Seikagaku. The Journal of Japanese Biochemical Society, 2003, Volume: 75, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Drug Design; Excitatory Amino Acid Antagonist

2003
ALS surrogate markers. MRS.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2004, Volume: 5 Suppl 1

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Creatine; Humans; Longitudinal Studies; Ma

2004
N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.
    Advances in experimental medicine and biology, 2006, Volume: 576

    Topics: Aging; Alcoholism; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Brain Injuries;

2006
Biological markers in the diagnosis and treatment of ALS.
    Journal of the neurological sciences, 1999, Volume: 165 Suppl 1

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Progression; Elec

1999
[Proton MR spectroscopy studies of the brain in ALS patients].
    Neurologia i neurochirurgia polska, 2001, Volume: 35, Issue:1 Suppl

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Disease Progression; Female; Front

2001

Trials

9 trials available for aspartic acid and Amyotrophic Lateral Sclerosis

ArticleYear
The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.
    European journal of radiology, 2015, Volume: 84, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cerebral Cortex; Choli

2015
Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
    Archives italiennes de biologie, 2009, Volume: 147, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Choline; Creatinine; Diffusio

2009
Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study.
    AJNR. American journal of neuroradiology, 2011, Volume: 32, Issue:9

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Female; Frontotemporal Lobar

2011
A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2003, Volume: 4, Issue:1

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain Chemistry; Brain-Derived Neur

2003
A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.
    Acta neurologica Scandinavica, 2003, Volume: 108, Issue:1

    Topics: Adult; Aged; Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cross-Over S

2003
Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis).
    Journal of the neurological sciences, 1995, Volume: 129 Suppl

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Female; Humans; Magnet

1995
Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.
    Neuroreport, 1998, Jun-01, Volume: 9, Issue:8

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Excitatory Amino Acid Antagonists; Female

1998
Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters.
    Acta neurologica Scandinavica, 2002, Volume: 106, Issue:1

    Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressur

2002
Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis.
    Acta neurologica Scandinavica, 2002, Volume: 106, Issue:1

    Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressur

2002

Other Studies

91 other studies available for aspartic acid and Amyotrophic Lateral Sclerosis

ArticleYear
Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants.
    Annals of clinical and translational neurology, 2023, Volume: 10, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Humans; Motor Neurons; Muscular Diseases; Mutation

2023
Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
    Scientific reports, 2019, 11-26, Volume: 9, Issue:1

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Choline; Creatine; Disease Progression;

2019
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 75

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Cycle Proteins; Female; Genetic Testing;

2020
MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:10

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Humans; Magnetic Resonance Imaging; Magnet

2021
Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
    Neurology, 2021, 08-24, Volume: 97, Issue:8

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cognitive Dysfunction; Disease Progressio

2021
Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
    PloS one, 2017, Volume: 12, Issue:5

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamic Acid; Glutamine; Humans;

2017
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline.
    Journal of Alzheimer's disease : JAD, 2018, Volume: 61, Issue:1

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; C9orf72 Protein; Cognitive Dysfunction; DNA Muta

2018
Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Disease Progression

2019
β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
    Environmental toxicology and pharmacology, 2013, Volume: 36, Issue:2

    Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Caspase 3; Choline; Cre

2013
Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis.
    Neurochemistry international, 2013, Volume: 63, Issue:6

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Erythrocyte Membrane; Female; Humans; Mal

2013
Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations.
    Journal of the American Chemical Society, 2013, Oct-23, Volume: 135, Issue:42

    Topics: Amyotrophic Lateral Sclerosis; Asparagine; Aspartic Acid; Humans; Models, Molecular; Molecular Struc

2013
An ALS disease mutation in Cdc48/p97 impairs 20S proteasome binding and proteolytic communication.
    Protein science : a publication of the Protein Society, 2015, Volume: 24, Issue:9

    Topics: Adenosine Triphosphatases; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Cycle Proteins; Humans

2015
The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2016, Volume: 27

    Topics: Aged; Aging; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Cell Death; Cross-Sectional S

2016
Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: Magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus.
    Cytotherapy, 2016, Volume: 18, Issue:6

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell- and Tissue-Based Therapy; Creatine; Femal

2016
Nicotinic receptor activation contrasts pathophysiological bursting and neurodegeneration evoked by glutamate uptake block on rat hypoglossal motoneurons.
    The Journal of physiology, 2016, 11-15, Volume: 594, Issue:22

    Topics: Action Potentials; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Brain Stem; Endoplasmic Re

2016
Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
    Somatosensory & motor research, 2017, Volume: 34, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Creatine; Female; F

2017
Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase.
    Neurobiology of disease, 2008, Volume: 32, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Line; Cytosol; Humans; Malate Dehydrogen

2008
Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2010, Volume: 11, Issue:1-2

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Diffusion Tensor Imaging; Disease P

2010
Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
    Neuroscience letters, 2009, Apr-24, Volume: 454, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Caspase 12; Cell Death; Cell Survival; Diseas

2009
In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
    Acta neurologica Scandinavica, 2010, Volume: 121, Issue:2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Survival; Cells, Cultured;

2010
Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.
    The European journal of neuroscience, 2009, Volume: 30, Issue:11

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Models,

2009
Multivariate statistical mapping of spectroscopic imaging data.
    Magnetic resonance in medicine, 2010, Volume: 63, Issue:1

    Topics: Adult; Algorithms; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Choline; Creatin

2010
VEGF up-regulation by G93A superoxide dismutase and the role of malate-aspartate shuttle inhibition.
    Neurobiology of disease, 2010, Volume: 37, Issue:3

    Topics: Aminooxyacetic Acid; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Carbon Dioxide; Cell Lin

2010
Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.
    Neuroradiology, 2010, Volume: 52, Issue:12

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Creatinine; Female; Humans; Magneti

2010
Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study.
    Folia neuropathologica, 2010, Volume: 48, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Membrane; Cytoplasm; Endoplasmic Reticul

2010
A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course.
    Muscle & nerve, 2010, Volume: 42, Issue:4

    Topics: Adult; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Disease Progr

2010
TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB.
    Molecular and cellular neurosciences, 2011, Volume: 46, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Death; Excitatory Amino Acid Transporter

2011
Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy.
    AJNR. American journal of neuroradiology, 2011, Volume: 32, Issue:2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Female; Gyrus Cinguli; Humans; M

2011
Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
    The European journal of neuroscience, 2011, Volume: 33, Issue:5

    Topics: Action Potentials; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Astrocytes; Bicuculline; B

2011
D11Y SOD1 mutation and benign ALS: a consistent genotype-phenotype correlation.
    Journal of the neurological sciences, 2011, Oct-15, Volume: 309, Issue:1-2

    Topics: Aged; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Genetic Associa

2011
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.
    Neurology, 2011, Oct-04, Volume: 77, Issue:14

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-

2011
Serum N-acetylaspartate level in amyotrophic lateral sclerosis.
    Archives of neurology, 2011, Volume: 68, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies;

2011
Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
    Molecular medicine (Cambridge, Mass.), 2012, Jul-18, Volume: 18

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Movement; Central Nervous System; Diseas

2012
Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis.
    Neurology, 2012, May-15, Volume: 78, Issue:20

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cross-Sect

2012
Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Choline; Creatine; Humans; Hydrogen; Mag

2012
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
    Neuropharmacology, 2013, Volume: 66

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Autoreceptors; Calcium; Disease Models, Anima

2013
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS.
    Neurology, 2013, Feb-12, Volume: 80, Issue:7

    Topics: Aged; Amyotrophic Lateral Sclerosis; Anisotropy; Aspartic Acid; Brain; Case-Control Studies; Creatin

2013
Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.
    Radiology, 2013, Volume: 267, Issue:3

    Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline

2013
Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.
    Radiology, 2013, Volume: 267, Issue:3

    Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline

2013
Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.
    Radiology, 2013, Volume: 267, Issue:3

    Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline

2013
Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.
    Radiology, 2013, Volume: 267, Issue:3

    Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline

2013
Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:3

    Topics: Acetates; Aged; Amines; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Survival; Creatine; Cyclo

2003
A screening for superoxide dismutase-1 D90A mutation in Italian patients with sporadic amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2002, Volume: 3, Issue:4

    Topics: Adult; Aged; Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; DNA Pri

2002
Identification of two novel mutations in the Cu/Zn superoxide dismutase gene with familial amyotrophic lateral sclerosis: mass spectrometric and genomic analyses.
    Journal of the neurological sciences, 2004, Mar-15, Volume: 218, Issue:1-2

    Topics: Age of Onset; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, Liquid; DNA Mutational A

2004
Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis.
    Journal of neurology, 2004, Volume: 251, Issue:10

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain Mapping; Case-Control Studies; Creatine;

2004
Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2004, Volume: 5, Issue:3

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline; Creatine; Cross-S

2004
Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution.
    The Journal of biological chemistry, 2005, Oct-28, Volume: 280, Issue:43

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Binding Sites; Circular Dichroism; Copper; Crystalliza

2005
Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
    Journal of neurochemistry, 2006, Volume: 96, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Aspartic Acid; Astrocytes; Bl

2006
Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
    Radiology, 2006, Volume: 239, Issue:3

    Topics: Adult; Age Factors; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Diffusion

2006
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy.
    Journal of negative results in biomedicine, 2006, May-29, Volume: 5

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Aci

2006
Cerebral degeneration predicts survival in amyotrophic lateral sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:11

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Female; Humans; Magnetic R

2006
Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 2007, Mar-15, Volume: 254, Issue:1-2

    Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Base Sequence; Catalytic Doma

2007
MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2007, Volume: 21, Issue:1

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Cell Transplantation; Creatine; Female;

2007
Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.
    Journal of neurology, 2007, Volume: 254, Issue:8

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Analysis of Variance; Aspartic Acid; Choline; Creatine;

2007
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    The European journal of neuroscience, 2007, Volume: 25, Issue:6

    Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Aspartic Acid; Disease Mo

2007
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Neurology, 2007, Apr-24, Volume: 68, Issue:17

    Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Creatine;

2007
Effect of branched-chain amino acids on glutamate metabolism in amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 1995, Volume: 129, Issue:1

    Topics: Adult; Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamic A

1995
[3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study.
    Brain research, 1994, Aug-29, Volume: 655, Issue:1-2

    Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Autoradiography; Femal

1994
[Free amino acid contents in the spinal cord of amyotrophic lateral sclerosis].
    Rinsho shinkeigaku = Clinical neurology, 1993, Volume: 33, Issue:9

    Topics: Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamates; Glutamic Acid;

1993
Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:1

    Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamates; Humans;

1994
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Jul-15, Volume: 90, Issue:14

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Biological Transport, Active; Choline O-Acety

1993
Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis.
    Brain research bulletin, 1993, Volume: 30, Issue:3-4

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Dipeptides; Humans; Middle Aged; S

1993
Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis.
    Neurological research, 1996, Volume: 18, Issue:3

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Death; Female; Frontal Lobe; Humans; Magnet

1996
Identification of brain metabolites by magnetic resonance spectroscopy in MND/ALS.
    Journal of the neurological sciences, 1996, Volume: 139 Suppl

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Chemistry; Creatine; gamma-Aminobutyric A

1996
Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
    Neurology, 1997, Volume: 48, Issue:4

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cerebellum; Choline; Creatine; Female; Hu

1997
Increased CSF glutamate following injection of ALS immunoglobulins.
    Neurology, 1997, Volume: 48, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Glutamic Acid; Immunoglobulins; Injections, I

1997
CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation.
    Journal of neurochemistry, 1998, Volume: 70, Issue:2

    Topics: Alanine; Alleles; Amyotrophic Lateral Sclerosis; Aspartic Acid; Erythrocytes; Genetic Carrier Screen

1998
Quantification of brain metabolites in ALS by localized proton magnetic spectroscopy.
    Neurology, 1998, Volume: 50, Issue:2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Creatine; Humans; Magnetic Resonan

1998
Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
    Neurology, 1998, Volume: 50, Issue:6

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Humans; Magnetic Resonance Imagin

1998
Expression, purification, and characterization of a familial amyotrophic lateral sclerosis-associated D90A Cu,Zn-superoxide dismutase mutant.
    Molecules and cells, 1998, Aug-31, Volume: 8, Issue:4

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chelating Agents; Co

1998
A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
    Neurology, 1998, Volume: 51, Issue:4

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatinine; Humans; Magnetic Res

1998
Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry.
    Neuroreport, 1998, Sep-14, Volume: 9, Issue:13

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Axons; Caudate Nucleus; Creatine; Disease Mod

1998
The free radical-generating function of a familial amyotrophic lateral sclerosis-associated D90A Cu,Zn-superoxide dismutase mutant.
    Biochemistry and molecular biology international, 1998, Volume: 46, Issue:6

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Free Radicals; Human

1998
1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.
    Neurology, 1999, Jul-13, Volume: 53, Issue:1

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Female; Glutamic Acid; Gluta

1999
Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS).
    Acta neurologica Scandinavica, 1999, Volume: 100, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Cell Death; Chromatography, High P

1999
Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain.
    Radiology, 1999, Volume: 212, Issue:3

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Creatine; Female; Humans; Magnetic Resona

1999
1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 1999, Oct-31, Volume: 169, Issue:1-2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain Chemistry; Creatine; Humans; Magnet

1999
Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase.
    Journal of neurochemistry, 2000, Volume: 74, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Transport System X-AG; Amyotrophic Lateral Sclerosis; Ani

2000
[Physiopathological and chemopathological mechanisms of central motor disorders in amyotrophic lateral sclerosis].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2000, Volume: 100, Issue:7

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Electromyography; Female; Glutamic

2000
CuZn-superoxide dismutase gene in sporadic amyotrophic lateral sclerosis patients from Russia: Asp90Ala (D90A) mutation and novel rare polymorphism IVS3+35 A>C.
    Human mutation, 2000, Volume: 16, Issue:3

    Topics: Adult; Aged; Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Asian People; Aspartic

2000
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Archives of neurology, 2001, Volume: 58, Issue:5

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Disease Progression; Female;

2001
1H spectroscopy in patients with amyotrophic lateral sclerosis.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2001, Volume: 11, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Case-Control Studies; Choline; Cre

2001
Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
    Neuroradiology, 2001, Volume: 43, Issue:7

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Choline; Creatine; Female; Fr

2001
Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients.
    Journal of the neurological sciences, 2001, Sep-15, Volume: 190, Issue:1-2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Electric Stimulation; Female; Hu

2001
Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Experimental neurology, 2001, Volume: 172, Issue:2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Female; Humans; Magnet

2001
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
    Neurology, 2002, Mar-12, Volume: 58, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Disease Progression; Female; Humans

2002
Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 2002, Jun-15, Volume: 198, Issue:1-2

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain Stem; Choline; Creatine; Humans; Magnetic Resona

2002
Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis.
    Acta neurologica Scandinavica, 1992, Volume: 86, Issue:5

    Topics: Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biopsy; Collagen; Female; Glutamate

1992
[Familial amyotrophic lateral sclerosis associated with Huntington chorea with increased aspartate level in the cerebrospinal fluid].
    Revue neurologique, 1992, Volume: 148, Issue:2

    Topics: Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Fem

1992
Excitatory amino acids in amyotrophic lateral sclerosis: an update.
    Annals of neurology, 1991, Volume: 30, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Glutamates; Glut

1991
Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS.
    Brain research, 1991, Aug-09, Volume: 556, Issue:1

    Topics: Amino Acids; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cerebral Cortex; Di

1991
Excitatory amino acids in amyotrophic lateral sclerosis.
    Annals of neurology, 1991, Volume: 29, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Glutamates; Huma

1991
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.
    Annals of neurology, 1990, Volume: 28, Issue:1

    Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Dipeptides; Female; Glutamat

1990
The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
    Annals of neurology, 1988, Volume: 24, Issue:3

    Topics: Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Cerebellar Cortex; Cerebral

1988